[Erythropoietin in 1991--pathophysiological and therapeutic aspects].
作者信息
Wiecek A
机构信息
Katedry i Kliniki Nefrologii Sl. AM, Katowicach.
出版信息
Przegl Lek. 1992;49(1-2):31-5.
PMID:1455002
Abstract
摘要
相似文献
1
[Erythropoietin in 1991--pathophysiological and therapeutic aspects].
Przegl Lek. 1992;49(1-2):31-5.
2
3
[Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
Pol Tyg Lek. 1990;45(38-39):782-6.
4
[The role of erythropoietin in the regulation of hematopoiesis and its therapeutic use].
Acta Haematol Pol. 1991;22(2):346-54.
5
6
Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.重组人促红细胞生成素治疗终末期肾病所致贫血的美国多中心试验。
Contrib Nephrol. 1989;76:166-78; discussion 212-8.
7
Treatment of anaemia in chronic renal failure.
Nurs Times. 1988;84(47):55-7.
8
9
Erythropoietin levels and androgens use: what is their relationship in the correction of anemia?促红细胞生成素水平与雄激素的使用：它们在纠正贫血方面有何关系？
Arch Intern Med. 2007 Feb 12;167(3):309. doi: 10.1001/archinte.167.3.309.
10
[Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Przegl Lek. 1990;47(11):741-5.
Zotero 插件